Drugmaker says weight loss drugs reduced Type 2 diabetes risk by 94%

The video discusses Zepbound, a drug that reduces the risk of type 2 diabetes by 94% in obese and overweight adults. Dr. Jane Morgan explains its mechanism, highlighting its dual hormone receptor action. The clinical study showed significant results in preventing diabetes progression, but weight gain returns after stopping the medication. Future directions include developing oral formulations for lifetime maintenance.

What is the significance of the study's findings regarding the prevention of diabetes progression?

What happens to weight gain after patients stop taking the medication according to the study?